| 16.78 Delayed Data As of 3:59pm ET |  +0.04 / +0.24%Today’s Change | 14.61 Today|||52-Week Range 28.17 | -4.50% Year-to-Date |
| Bristol-Myers, Ono, Bayer Team Up for Colorectal Cancer Study Jul 19 / Zacks.com - Paid Partner Content | Bayer-J&J Announce Positive Xarelto Data in Children with VTE Jul 09 / Zacks.com - Paid Partner Content |
| 6 Low Price-to-Book Value Stocks to Buy for Solid Returns Jul 17 / Zacks.com - Paid Partner Content | Are Investors Undervaluing Bayer (BAYRY) Right Now? Jul 09 / Zacks.com - Paid Partner Content |
| Dow 30 Stock Roundup: Cisco to Buy Acacia, Microsoft & ServiceNow Partnernership Jul 12 / Zacks.com - Paid Partner Content |
| Previous close | 16.74 |
| Today’s open | 16.80 |
| Day’s range | 16.65 - 16.81 |
| Volume | 331,333 |
| Average volume (3 months) | 945,963 |
| Market cap | $62.4B |
| Earnings growth (last year) | -77.23% |
| Earnings growth (this year) | +12.52% |
| Earnings growth (next 5 years) | +9.06% |
| Revenue growth (last year) | +18.25% |
| P/E ratio | 3.9 |
| Price/Sales | 1.39 |
| Price/Book | 1.19 |
| No competitors data available. |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $0.49 |
| Annual revenue (last year) | $46.7B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 4.28% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman- Management Board Werner Baumann |
Chief Financial Officer Wolfgang U. Nickl |
Corporate headquarters Leverkusen, Nordrhein-westfalen |
